New report shows people with advanced or terminal illness support law change on assisted dying
Survey we supported shares findings that people with advanced or terminal illness support a change in the law on assisted dying
Trustees' Week 2019: thank you to our trustees
This week is Trustees’ Week, an annual event to showcase the great work trustees do for charities up and down the UK.
Could sleep boost waste disposal in the brain and prevent Parkinson’s?
Alongside Alzheimer’s Research UK, we’re funding new research that will investigate whether boosting the brain’s self-cleaning system could be the key to new treatments.
Caution when looking at cell recycling in Parkinson’s
Researchers at the Oxford Parkinson’s Disease Centre have shown that cell recycling in Parkinson’s may play a more complex role than previously thought. These new results have been published in the journal of Cell Reports.
Scotland’s hospitals fail to give people with Parkinson’s medication on time more than 100,000 times each year
Media release outlining launch of new Get It On Time report for Scotland
Revolutionary research advocate Ken Bowler dies aged 76
The Parkinson’s community in Scotland, and beyond, has lost one of its giants with the passing of Professor Ken Bowler. Ken revolutionised the relationship between researchers and people living with Parkinson’s.
New research: Ex-footballers more likely to get Parkinson's
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
MPs show their support for our Get It On Time campaign
Update on our visit to Parliament to promote our latest report to improve medication management for people with Parkinson's in hospital
Cannabis and Parkinson's
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
Can cannabis stop Parkinson's hallucinations?
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.